Deka Bank Deutsche Girozentrale Aclaris Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	BUY	$9.74 - $17.92 $19,480 - $35,840	2,000 Added 10.0%	22,000 $388,000
Q4 2021 Feb 02, 2022	BUY	$12.27 - $18.49 $245,400 - $369,799	20,000 New	20,000 $288,000
Q3 2019 Nov 14, 2019	SELL	$0.79 - $2.47 $16,748 - $52,364	-21,200 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$2.13 - $7.06 $18,105 - $60,010	8,500 Added 66.93%	21,200 $45,000
Q1 2019 May 10, 2019	BUY	$5.63 - $7.84 $11,823 - $16,464	2,100 Added 19.81%	12,700 $187,000
Q4 2018 Feb 12, 2019	SELL	$6.3 - $15.4 $13,230 - $32,340	-2,100 Reduced 16.54%	10,600 $74,000
Q1 2018 May 03, 2018	BUY	$17.08 - $25.64 $216,915 - $325,628	12,700 New	12,700 $234,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $253M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.